Treatment GuideJust DiagnosedSex & DatingAfrican AmericanStigmaAsk the HIV DocPrEP En EspañolNewsVoicesPrint IssueVideoOut 100
CONTACTCAREER OPPORTUNITIESADVERTISE WITH USPRIVACY POLICYPRIVACY PREFERENCESTERMS OF USELEGAL NOTICE
© 2024 Pride Publishing Inc.
All Rights reserved
All Rights reserved
By continuing to use our site, you agree to our Private Policy and Terms of Use.
hepatitis C virus successfully treated with a triple-drug antiretroviral regimen are no more likely to experience rapid liver disease progression than adults infected only with HCV, according to a study in the January 15 edition of the journal Clinical Infectious Diseases. The researchers say early initiation of anti-HIV therapy reduces necroinflammation, which results in slower progressing and less severe liver disease. HIV coinfection can increase levels of hepatitis C virus in the bloodstream by 2- to 8-fold, French researchers reported in the November issue of the Journal of Hepatology. HIV-HCV coinfection also accelerates the risk of cirrhosis and of the rare but deadly condition fibrosing cholestatic hepatitis, they said. A study of nearly 5,000 HIV patients showed no evidence that any specific anti-HIV drug may be more poorly tolerated than others and lead to treatment discontinuation in study subjects also coinfected with HCV. Writing in the journal Antiviral Therapy, the researchers said their analysis has shown that while HIV-HCV'coinfected adults were more likely to quit therapy because of drug-related toxicity than those infected only with HIV, toxicity issues were not related to any specific anti-HIV medication. Blood-based levels of hepatitis C virus can predict the risks for end-stage liver disease and death in both patients infected only with HCV and in HIV-HCV'coinfected adults, according to a study in the December issue of the journal Hepatology. As HCV levels in the blood increased, so did the risk of death from end-stage liver disease, according to the study of nearly 400 HCV patients. Markers of liver damage that can be detected in the blood provide an accurate picture of the extent of liver disease in HIV-HCV'coinfected adults, according to a study in the December 15 edition of the Journal of Acquired Immune Deficiency Syndromes. They said their findings suggest these tests could be used in place of expensive and invasive liver biopsies. The FDA approved the hepatitis C treatment Ribasphere in December. The drug, jointly marketed by Par Pharmaceutical and Three Rivers Pharmaceuticals, is available in 200-, 400-, and 600-milligram tablets for use in combination with interferon alfa-2a. The FDA has granted fast-track review status to Vertex's experimental hepatitis C treatment VX-950. A Phase Ib study of the drug has shown it had significant and rapid virus-lowering effects. A Phase II U.S. study is expected to begin this year. Pharmaceutical firms Idenix and Novartis in January filed for FDA approval of their hepatitis B treatment telbivudine. A clinical trial including more than 1,300 hepatitis B patients showed telbivudine was more effective in suppressing HBV in the bloodstream than standard lamivudine therapy. Some hepatitis B test kits manufactured by Johnson & Johnson were recalled in January because of higher than normal odds of returning false-positive results. Three defective lots of the Vitros Immunodiagnostic HBsAG Confirmatory Kit had been distributed in Europe and the United States. Johnson & Johnson officials say they are unaware of anyone receiving an inaccurate diagnosis, but they urge health care facilities to review previous test results.
Want more breaking equality news & trending entertainment stories?
Check out our NEW 24/7 streaming service: the Advocate Channel!
Download the Advocate Channel App for your mobile phone and your favorite streaming device!
From our Sponsors
Most Popular
Before AIDS, gay artist Rex drew hot men on the prowl — then he disappeared
April 11 2024 3:15 PM
Diets that mimic fasting reverse aging: study
March 07 2024 5:28 PM
The Most Amazing HIV Allies & Advocates of 2023
November 03 2023 12:51 PM
PrEP without a prescription now a reality in California
February 06 2024 8:37 PM
This OnlyFans Star Is Trying to Raise $100K to Fight HIV
December 26 2023 3:05 PM
Injectable HIV treatment, prevention: Everything you need to know
March 26 2024 3:28 PM
The naked Black body takes center stage in this HIV campaign
January 03 2024 1:07 PM
8 dating tips for gay men from a gay therapist
March 21 2024 2:50 PM
Mr. Gay World wants to make sure you're OK
January 02 2024 4:56 PM
Plus: Featured Video
Latest Stories
The government failed on mpox. Ritchie Torres's new bill addresses that
April 18 2024 1:21 PM
On Anal Sex Day, crack up with The Bottom's Digest
April 18 2024 10:22 AM
Todrick Hall has long supported the communities he comes from
April 17 2024 12:02 PM
Our May/June issue of Plus is here!
April 17 2024 12:00 PM
Giselle Byrd is taking center stage — and helping others do the same
April 10 2024 2:24 PM
Discover endless fun at The Pride Store: Games & electronics for all ages
April 09 2024 4:25 PM
Mean Girls' Daniel Franzese on playing an HIV+ character
April 09 2024 3:57 PM
HIV-positive Air Force, Navy servicemembers victorious in lawsuit
April 09 2024 3:02 PM
Unlocking a new level of beauty with Dr Botanicals' ethical skincare line
April 08 2024 3:40 PM
Unleash your wild side with The Pride Store’s beginner’s guide to kink
April 08 2024 3:35 PM
Why are mpox cases in the U.S. on the rise again?
April 08 2024 1:30 PM
Happy national foreskin day!
April 04 2024 1:45 PM
Adult entertainment icons Derek Kage & Cody Silver lead fight for free speech
April 03 2024 3:06 PM
LGBTQ+ patients twice as likely to face discrimination: survey
April 02 2024 4:57 PM
Spring into The Pride Store’s top new arrivals for April
April 02 2024 4:39 PM
Nashville PD Must Pay HIV-Positive Man Denied a Job
April 01 2024 6:22 PM
Common has a message on how to foster self-love
March 29 2024 7:33 PM
Listen to Dr. Levine: Take syphilis seriously
March 28 2024 6:40 PM
Breaking boundaries in gender-free fashion with Stuzo Clothing
March 27 2024 2:15 PM